Pivotal Phase 2 trial of RP-A501 for Danon disease to resume in 1H 2026 KRESLADI™ for severe LAD-I on track for March 28, 2026 PDUFA date Leadership updates with the appointments of Dr. Syed Rizvi, Chief Medical Officer, Christopher Stevens, Chief Operating Officer, and Sarbani Chaudhuri, Chief Commercial & Medical Affairs Officer Cash, cash equivalents … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#SITC–Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial multi-omics data at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting on November 7-10, 2025 in National Harbor, Maryland. The company will showcase how researchers can generate a combination of … [Read more…]
Clinisys expands laboratory innovation with the launch of CLS v2025.2, delivering breakthrough healthcare capabilities with tailored solutions for Clinical Pathology and Genomics labs in North America, and introducing CLS CARE, an AI-powered support agent. TUCSON, Ariz.–(BUSINESS WIRE)–Clinisys is now enhancing its August 2025 release of Clinisys™ Laboratory Solution (CLS) v2025.1—which delivered significant advancements such as … [Read more…]
Continued strong commercial performance and unprecedented pipeline delivery in the year to date CAMBRIDGE, England–(BUSINESS WIRE)–AstraZeneca: Revenue and EPS summary 9M 2025 % Change Q3 2025 % Change $m Actual CER1 $m Actual CER – Product Sales 41,035 9 9 14,365 11 9 – Alliance Revenue 2,108 41 … [Read more…]
BALLERUP, Denmark–(BUSINESS WIRE)–In the first nine months of 2025, LEO Pharma continued its robust revenue growth, with significantly improved profitability and free cash flow. As expected, growth accelerated in the third quarter, with the global rollout of Anzupgo® gaining further momentum after its September launch in the U.S. The 2025 financial outlook is updated to … [Read more…]
Sonde collaborates with Qualcomm to place vocal biomarker technology in small-footprint chipsets for fast-growing personal device segments BOSTON–(BUSINESS WIRE)–Sonde Health, a global leader in voice AI-based health technology, announced a collaboration with Qualcomm Technologies, Inc. to enable Sonde’s embedded vocal biomarker platform on devices powered by the Snapdragon® AR1 Gen 1, processor. This collaboration enables … [Read more…]
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today issued the following statement in response to the Delaware Chancery Court’s decision denying Pfizer’s request for a temporary restraining order to prevent Metsera, Inc. from terminating the existing merger agreement in favor of a competing proposal from Novo Nordisk. “We remain confident in the merits of our claims … [Read more…]
Rick Rosen, Orly Adelson, Sandra Stern and Lynn Williams Honored Hosted by Jimmy Kimmel, with Jennifer Garner, Conan O’Brien and Jackson Browne in Attendance LOS ANGELES–(BUSINESS WIRE)–#AnnualGala—Saban Community Clinic announced today that its 49th Annual Dinner Gala raised $2.4 million to support the Clinic’s mission of providing outstanding, compassionate care to anyone who needs it. … [Read more…]
The combined leadership teams from Vascular Technology and Parks Medical Electronics will drive the platform’s next phase of growth. NEW YORK–(BUSINESS WIRE)–JLL Partners (“JLL” or the “Firm”), a New York-based middle market private equity firm focused on investing in the healthcare, aerospace and defense, and business services sectors, today announced its acquisition of Parks Medical … [Read more…]
Navitus MedicareRx maintained a 4.5 out of 5 Part D Star Rating for 2026, recognizing ongoing clinical quality and excellent service to beneficiaries MADISON, Wis.–(BUSINESS WIRE)–Navitus, the nation’s first and largest transparent, pass-through pharmacy benefit manager (PBM), announced today that its prescription drug plan Navitus MedicareRx (PDP) maintained a 4.5 out of 5 Part D … [Read more…]
